anthrax lethal factor inhibitor (Cengent)

N/A

Report date: 2025/03/14 20:00:48

NME

Base Information

Drug Nameanthrax lethal factor inhibitor (Cengent)

Drug Alias NameALF inhibitor (SBI)anthrax therapeutic (SBI)ALF inhibitor (Cengent)anthrax lethal factor inhibitor (Structural Bioinformatics)ALF inhibitor (Structural Bioinformatics)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsAnthrax

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCengent Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCengent Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsAnthrax

Other Information

ATC CodeN/A